Global Innovative Platforms (GIPL) Accumulated Expenses (2025 - 2026)
Global Innovative Platforms' (GIPL) quarterly Accumulated Expenses came in at $2000.0 in Q2 2026, little changed quarter-over-quarter from $2000.0 in Q1 2026.
Powered by 
Analysis
Global Innovative Platforms (GIPL) Accumulated Expenses (2025 - 2026) Analysis & Trends
Global Innovative Platforms has disclosed Accumulated Expenses across 2 years of filings, most recently posting $2000.0 for Q2 2026.
- In Q2 2026, Accumulated Expenses changed N/A year-over-year to $2000.0; the TTM figure through Jun 2026 stood at $2000.0 (changed N/A YoY), while the FY2025 annual figure was $10000.0, changed N/A from the prior year.
- Accumulated Expenses came in at $2000.0 for Q2 2026 at Global Innovative Platforms, roughly flat from $2000.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $10000.0 in Q3 2025 to a low of $2000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 10,000.00 |